To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene FAM127ATABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
471 supporting clones for gene FAM127A back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
TI_57215807   .a-u 1 to 884 28 to 909   tiling clone,   882/911
(96 %)
13 diff
(98.6 %id)
BI755207 brain .a-u 2 to 884 1 to 881       881/883
(99 %)
13 diff
(98.6 %id)
TI_57181058   .a-u 2 to 865 52 to 923       872/926
(94 %)
34 diff
(96.4 %id)
CD580069 brain .a-u 5 to 518 1 to 507       507/660
(76 %)
11 diff
(98.4 %id)
CX784259 human embryonic stem cells .a-u 7 to 520 1 to 514       514/514
(100 %)
0 diff
(100 %id)
TI_57176947   .a-u 7 to 489 58 to 542       485/696
(69 %)
10 diff
(98.6 %id)
NM_001078171.1   .a-u 7 to 1242 1 to 1236 exact RefSeq, AAA   1236/1236
(100 %)
0 diff
(100 %id)
BM763063 myeloma .a-u 10 to 464 1 to 455       455/455
(100 %)
0 diff
(100 %id)
CN401398 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a-u 17 to 472 11 to 466       456/466
(97 %)
6 diff
(98.8 %id)
N73121 liver and spleen .a-u 17 to 425 1 to 408       408/446
(91 %)
14 diff
(96.9 %id)
BF347085 anaplastic oligodendroglioma with 1p/19qloss, brain .a-u 19 to 805 1 to 782       782/829
(94 %)
24 diff
(97.2 %id)
BI831269 brain, medulla .a-u 21 to 489 1 to 471       471/625
(75 %)
3 diff
(99.6 %id)
BF967420 brain, hypothalamus .a-u 22 to 689 1 to 666       666/783
(85 %)
6 diff
(99.3 %id)
BQ068165 brain .a-u 22 to 747 1 to 737       737/995
(74 %)
19 diff
(98.1 %id)
BQ441921 epithelioid carcinoma, Pancreas .a-u 22 to 525 1 to 504       504/955
(52 %)
8 diff
(99.2 %id)
BI768563 pooled lung and spleen .a-u 23 to 865 1 to 853       853/856
(99 %)
28 diff
(96.8 %id)
AW160989 brain, frontal lobe .a-u 27 to 465 1 to 439       439/439
(100 %)
0 diff
(100 %id)
BX109352 liver and spleen .a-u 32 to 630 1 to 600       600/600
(100 %)
3 diff
(99.5 %id)
CN401410 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a-u 34 to 715 1 to 682       682/682
(100 %)
0 diff
(100 %id)
BQ962294 epithelioid carcinoma cell line, Pancreas .a-u 34 to 719 1 to 695       695/941
(73 %)
23 diff
(97.6 %id)
TI_57221318   .a-u 37 to 875 59 to 903       845/939
(89 %)
6 diff
(99.4 %id)
BQ961763 epithelioid carcinoma cell line, Pancreas .a-u 38 to 733 1 to 704       704/965
(72 %)
29 diff
(97.0 %id)
TI_57189434   .a-u 38 to 747 49 to 755       707/710
(99 %)
6 diff
(99.2 %id)
BE904521 epithelioid carcinoma, Pancreas .a-u 39 to 745 1 to 688       688/907
(75 %)
14 diff
(98.5 %id)
BI860478 breast, mammary adenocarcinoma, cell line .a-u 39 to 747 1 to 706       706/709
(99 %)
6 diff
(99.2 %id)
BQ675717 epidermoid carcinoma, cell line, salivary gland .a-u 39 to 544 1 to 507       507/892
(56 %)
6 diff
(99.4 %id)
CN401400 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a-u 43 to 191 1 to 149       149/149
(100 %)
2 diff
(98.7 %id)
AA076516 Pancreas .a-u 46 to 446 1 to 401       401/403
(99 %)
18 diff
(95.6 %id)
BI757879 brain .a-u 46 to 621 1 to 576       576/576
(100 %)
6 diff
(99.0 %id)
BU176767 eye, retinoblastoma .a-u 47 to 547 1 to 502       502/965
(52 %)
8 diff
(99.2 %id)
CN401381 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a-u 48 to 344 1 to 299       299/299
(100 %)
2 diff
(99.4 %id)
BF525408 brain, glioblastoma with EGFR amplification .a-u 52 to 790 1 to 732       732/1087
(67 %)
20 diff
(98.2 %id)
AA350535 brain .a-u 53 to 442 1 to 392       392/392
(100 %)
9 diff
(97.8 %id)
CN401383 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a-u 53 to 522 1 to 473       473/473
(100 %)
5 diff
(99.0 %id)
BG280768 melanotic melanoma, skin .a-u 53 to 497 1 to 451       451/777
(58 %)
12 diff
(98.5 %id)
TI_44342953   .a-u 53 to 790 121 to 860       740/862
(85 %)
6 diff
(99.4 %id)
BI666930 brain, hypothalamus .a-u 54 to 790 1 to 739       739/741
(99 %)
6 diff
(99.2 %id)
BM782129 myeloma .a-u 54 to 464 1 to 411       411/411
(100 %)
0 diff
(100 %id)
CR747801 skin, squamous cell carcinoma .a-u 55 to 530 1 to 476       476/476
(100 %)
0 diff
(100 %id)
N30534 melanocyte .a-u 55 to 402 1 to 347       347/476
(72 %)
5 diff
(99.0 %id)
BG167238 hypernephroma, cell line, Kidney .a-u 55 to 802 1 to 756       756/847
(89 %)
45 diff
(94.7 %id)
BG679393 skin, squamous cell carcinoma .a-u 55 to 867 1 to 812       812/812
(100 %)
4 diff
(99.6 %id)
BG036703 brain, hippocampus .a-u 56 to 728 1 to 671   fully sequenced,   671/671
(100 %)
14 diff
(98.0 %id)
BG475753 melanotic melanoma, skin .a-u 56 to 426 1 to 372       372/1065
(34 %)
6 diff
(99.5 %id)
BQ947050 epidermoid carcinoma, cell line, lung .a-u 56 to 673 1 to 622       622/1029
(60 %)
11 diff
(99.0 %id)
N44571 melanocyte .a-u 57 to 302 1 to 243       243/243
(100 %)
5 diff
(98.0 %id)
BG255659 adenocarcinoma, cell line, Prostate .a-u 58 to 678 1 to 620       620/624
(99 %)
8 diff
(98.8 %id)
BU193999 melanotic melanoma, skin .a-u 58 to 530 85 to 557       473/1223
(38 %)
5 diff
(99.6 %id)
BM148972 leukopheresis .a-u 58 to 563 1 to 506       506/507
(99 %)
3 diff
(99.5 %id)
BP307359 brain .a-u 59 to 650 1 to 592       592/592
(100 %)
4 diff
(99.4 %id)
W52785 senescent fibroblast .a-u 60 to 404 1 to 344       344/344
(100 %)
8 diff
(97.7 %id)
TI_57183993   .a-u 62 to 903 56 to 902       847/903
(93 %)
6 diff
(99.4 %id)
BG031272 breast, mammary adenocarcinoma, cell line .a-u 64 to 603 33 to 575       543/1187
(45 %)
16 diff
(98.7 %id)
CN401406 embryonic stem cells, DMSO-treated H9 cellline .a-u 65 to 819 1 to 757       757/757
(100 %)
3 diff
(99.7 %id)
CF127452 Chondrosarcoma Lung Metastasis cell lines, lung .a-u 65 to 764 1 to 700       700/700
(100 %)
0 diff
(100 %id)
TI_154192864   .a-u 65 to 1054 51 to 1029 P122A S125K L139S P140A C145W ...     979/1019
(96 %)
25 diff
(97.6 %id)
AL545178 placenta, Placenta Cot 25-normalized .a-u 66 to 1037 1 to 962 R40X A41X S108T W109G L167P ... fully sequenced,   962/962
(100 %)
13 diff
(98.7 %id)
BM921055 pooled brain, lung, testis .a-u 66 to 871 19 to 830       812/1066
(76 %)
17 diff
(98.5 %id)
BQ671551 epidermoid carcinoma, cell line, salivary gland .a-u 66 to 481 1 to 414       414/988
(41 %)
4 diff
(99.6 %id)
CN401407 embryonic stem cells, cell lines H1, H7, andH9 .a-u 67 to 520 1 to 454       454/459
(98 %)
3 diff
(99.4 %id)
BX376701 Neuroblastoma Cot 50-normalized .a-u 67 to 1020 1 to 942   fully sequenced,   942/942
(100 %)
11 diff
(98.9 %id)
CN401393 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a-u 68 to 519 1 to 453       453/453
(100 %)
3 diff
(99.4 %id)
AL556623 placenta .a-u 68 to 632 2 to 554   fully sequenced,   553/554
(99 %)
5 diff
(99.1 %id)
CN401389 embryonic stem cells, DMSO-treated H9 cellline .a-u 69 to 579 1 to 511       511/511
(100 %)
1 diff
(99.9 %id)
CN481491 eye .a-u 69 to 575 1 to 507       507/507
(100 %)
3 diff
(99.5 %id)
BE788677 large cell carcinoma, lung .a-u 69 to 856 1 to 795       795/872
(91 %)
36 diff
(95.9 %id)
BI195813 brain, neuroblastoma .a-u 69 to 887 1 to 810       810/810
(100 %)
25 diff
(97.0 %id)
BM460007 leiomyosarcoma, uterus .a-u 69 to 746 1 to 685       685/1129
(60 %)
19 diff
(98.4 %id)
BM477699 leiomyosarcoma, uterus .a-u 69 to 479 1 to 411       411/1241
(33 %)
0 diff
(100 %id)
AA295022 Bone .a-u 70 to 354 1 to 285       285/285
(100 %)
2 diff
(99.3 %id)
CN401386 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a-u 70 to 520 1 to 454       454/454
(100 %)
4 diff
(99.2 %id)
CN401394 embryonic stem cells, cell lines H1, H7, andH9 .a-u 70 to 595 1 to 527       527/527
(100 %)
3 diff
(99.5 %id)
CN401409 embryonic stem cells, DMSO-treated H9 cellline .a-u 70 to 509 1 to 440       440/440
(100 %)
0 diff
(100 %id)
CR623551 Neuroblastoma Cot 50-normalized .a-u 70 to 1239 1 to 1170 exact     1170/1170
(100 %)
0 diff
(100 %id)
BQ639965 eye, retina .a-u 70 to 584 1 to 515       515/515
(100 %)
0 diff
(100 %id)
BF345173 anaplastic oligodendroglioma with 1p/19qloss, brain .a-u 70 to 771 1 to 694       694/953
(72 %)
20 diff
(98.0 %id)
BF529261 anaplastic oligodendroglioma with 1p/19qloss, brain .a-u 70 to 675 1 to 604       604/604
(100 %)
2 diff
(99.7 %id)
BG117504 adenocarcinoma, cell line, Liver .a-u 70 to 839 1 to 763       763/990
(77 %)
24 diff
(97.6 %id)
BU161474 melanotic melanoma, skin .a-u 70 to 644 1 to 581       581/955
(60 %)
21 diff
(97.9 %id)
BU507308 leiomyosarcoma, uterus .a-u 70 to 689 1 to 623       623/905
(68 %)
15 diff
(98.4 %id)
CD252159 White Matter .a-u 70 to 463 17 to 411       395/1073
(36 %)
3 diff
(99.8 %id)
TI_154193530   .a-u 70 to 865 50 to 833       784/987
(79 %)
9 diff
(99.1 %id)
TI_154194486   .a-u 70 to 1076 45 to 1034 P119H L120C P121R P122R L123W ...     990/1047
(94 %)
38 diff
(96.4 %id)
Y13374 normalized brain .a-u 70 to 1247 9 to 1186 exact     1178/1186
(99 %)
6 diff
(99.5 %id)
AF038168 brain .a-u 71 to 1242 1 to 1172 exact tiling clone, AAA   1172/1172
(100 %)
0 diff
(100 %id)
AF052096 brain .a-u 71 to 1242 1 to 1172 exact AAA   1172/1172
(100 %)
0 diff
(100 %id)
F13347 brain, total brain .a-u 71 to 351 1 to 281       281/281
(100 %)
3 diff
(99.0 %id)
CN401395 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a-u 71 to 508 2 to 439       438/439
(99 %)
6 diff
(98.7 %id)
CD676235 eye, lens .a-u 71 to 725 1 to 655       655/655
(100 %)
0 diff
(100 %id)
N34581 melanocyte .a-u 71 to 445 1 to 375       375/381
(98 %)
8 diff
(98.0 %id)
BF528251 anaplastic oligodendroglioma with 1p/19qloss, brain .a-u 71 to 759 1 to 686       686/687
(99 %)
10 diff
(98.6 %id)
BC106076 Liver, adenocarcinoma .a-u 71 to 1242 1 to 1168 L43P P44S L45S E46R P47R ... AAA   1168/1168
(100 %)
2 diff
(99.9 %id)
BG122473 adenocarcinoma, cell line, Liver .a-u 71 to 794 1 to 710       710/870
(81 %)
30 diff
(96.6 %id)
CB215031 normal endometrium, late proliferativephase, cycle day 13, uterus .a-u 71 to 676 1 to 606       606/606
(100 %)
0 diff
(100 %id)
BQ892903 epidermoid carcinoma, cell line, salivary gland .a-u 71 to 675 1 to 605       605/976
(61 %)
13 diff
(98.7 %id)
BU528579 epidermoid carcinoma, cell line, lung .a-u 71 to 908 1 to 846       846/846
(100 %)
9 diff
(99.0 %id)
CF127844 Chondrosarcoma Lung Metastasis cell lines, lung .a-u 71 to 851 1 to 771       771/773
(99 %)
9 diff
(98.9 %id)
CF131048 Chondrosarcoma Lung Metastasis cell lines, lung .a-u 71 to 820 1 to 746       746/746
(100 %)
6 diff
(99.2 %id)
CN401408 embryonic stem cells, cell lines H1, H7, andH9 .a-u 72 to 499 1 to 428       428/428
(100 %)
1 diff
(99.8 %id)
BE782100 eye, retinoblastoma .a-u 72 to 790 1 to 715       715/1043
(68 %)
20 diff
(98.1 %id)
BF348128 anaplastic oligodendroglioma with 1p/19qloss, brain .a-u 72 to 770 1 to 698       698/1055
(66 %)
6 diff
(99.5 %id)
BG910493 anaplastic oligodendroglioma with 1p/19qloss, brain .a-u 72 to 862 14 to 800       787/816
(96 %)
6 diff
(99.3 %id)
BI755722 brain .a-u 72 to 621 1 to 551       551/551
(100 %)
1 diff
(99.9 %id)
BI772325 pooled lung and spleen .a-u 72 to 820 1 to 767       767/773
(99 %)
34 diff
(95.7 %id)
BM016200 breast, mammary adenocarcinoma, cell line .a-u 72 to 865 1 to 794       794/795
(99 %)
23 diff
(97.2 %id)
BQ231364 melanotic melanoma, skin .a-u 72 to 685 1 to 617       617/877
(70 %)
25 diff
(97.2 %id)
BU166157 melanotic melanoma, skin .a-u 72 to 525 1 to 454       454/458
(99 %)
1 diff
(99.8 %id)
DR159070 human embryonic stem cells differentiated toan early endodermal cell type .a-u 72 to 523 15 to 466       452/466
(96 %)
5 diff
(99.0 %id)
TI_57217141   .a-u 72 to 871 34 to 833       800/835
(95 %)
12 diff
(98.6 %id)
TI_57150171   .a-u 72 to 865 24 to 812       789/815
(96 %)
31 diff
(96.2 %id)
TI_57180180   .a-u 72 to 820 41 to 807       767/813
(94 %)
34 diff
(95.9 %id)
TI_59394597   .a-u 72 to 865 91 to 884       794/795
(99 %)
23 diff
(97.2 %id)
CN401412 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a-u 73 to 514 1 to 444       444/444
(100 %)
6 diff
(98.7 %id)
BI256955 cervical carcinoma cell line, cervix .a-u 73 to 931 1 to 848       848/914
(92 %)
24 diff
(97.4 %id)
CN401405 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a-u 74 to 546 1 to 473       473/473
(100 %)
0 diff
(100 %id)
W03520 melanocyte .a-u 74 to 509 1 to 427       427/436
(97 %)
11 diff
(97.5 %id)
AW409846 muscle, rhabdomyosarcoma .a-u 74 to 654 17 to 597       581/597
(97 %)
6 diff
(99.0 %id)
AW410876 muscle, rhabdomyosarcoma .a-u 74 to 432 17 to 375       359/375
(95 %)
6 diff
(98.4 %id)
BG424569 Kidney, renal cell adenocarcinoma .a-u 74 to 705 1 to 637       637/637
(100 %)
15 diff
(97.7 %id)
BM458887 melanotic melanoma, skin .a-u 74 to 732 1 to 663       663/1132
(58 %)
32 diff
(97.2 %id)
CF127597 Chondrosarcoma Lung Metastasis cell lines, lung .a-u 74 to 824 1 to 751       751/751
(100 %)
5 diff
(99.4 %id)
TI_154193142   .a-u 74 to 923 51 to 894       844/1000
(84 %)
17 diff
(98.3 %id)
BF725553 eye, Iris .a-u 75 to 559 1 to 485       485/485
(100 %)
2 diff
(99.6 %id)
CN401384 embryonic stem cells, cell lines H1, H7, andH9 .a-u 75 to 523 25 to 473       449/473
(94 %)
6 diff
(98.8 %id)
CN401396 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a-u 75 to 469 1 to 395       395/395
(100 %)
1 diff
(99.8 %id)
BF528287 anaplastic oligodendroglioma with 1p/19qloss, brain .a-u 75 to 755 1 to 676       676/705
(95 %)
6 diff
(99.2 %id)
BF338604 brain, glioblastoma with EGFR amplification .a-u 75 to 771 1 to 696       696/842
(82 %)
18 diff
(97.9 %id)
BF526231 brain, glioblastoma with EGFR amplification .a-u 75 to 590 13 to 530       518/1126
(46 %)
7 diff
(99.4 %id)
BG574783 breast, mammary adenocarcinoma, cell line .a-u 75 to 866 1 to 795       795/795
(100 %)
5 diff
(99.4 %id)
BG761040 melanotic melanoma, high MDR (cell line), skin .a-u 75 to 1007 1 to 937       937/944
(99 %)
42 diff
(95.6 %id)
BG910784 anaplastic oligodendroglioma with 1p/19qloss, brain .a-u 75 to 873 11 to 813       803/814
(98 %)
18 diff
(97.8 %id)
BI763700 pooled colon, kidney, stomach .a-u 75 to 621 1 to 546       546/546
(100 %)
11 diff
(98.0 %id)
BI767902 pooled lung and spleen .a-u 75 to 903 1 to 834       834/835
(99 %)
9 diff
(99.0 %id)
BM015396 breast, mammary adenocarcinoma, cell line .a-u 75 to 824 1 to 747       747/750
(99 %)
8 diff
(99.0 %id)
BQ720028 sympathetic trunk .a-u 75 to 471 1 to 397       397/401
(99 %)
1 diff
(99.8 %id)
CF128083 Chondrosarcoma Lung Metastasis cell lines, lung .a-u 75 to 465 1 to 392       392/392
(100 %)
3 diff
(99.3 %id)
TI_59393629   .a-u 75 to 824 90 to 836       747/750
(99 %)
8 diff
(99.0 %id)
EB387106 eye, optic nerve .a-u 75 to 899 1 to 825       825/825
(100 %)
0 diff
(100 %id)
TI_154189181   .a-u 75 to 851 50 to 820       771/882
(87 %)
10 diff
(98.9 %id)
TI_154193909   .a-u 75 to 923 51 to 894       844/958
(88 %)
37 diff
(96.2 %id)
CN401397 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a-u 76 to 414 1 to 339       339/339
(100 %)
0 diff
(100 %id)
BE882932 leiomyosarcoma, uterus .a-u 76 to 770 1 to 678       678/899
(75 %)
29 diff
(96.8 %id)
BF338464 brain, glioblastoma with EGFR amplification .a-u 76 to 765 1 to 686       686/768
(89 %)
9 diff
(98.9 %id)
BI771287 pooled lung and spleen .a-u 76 to 901 1 to 828       828/830
(99 %)
3 diff
(99.7 %id)
BQ923160 eye, normal pigmented retinal epithelium .a-u 76 to 527 1 to 452       452/1260
(35 %)
10 diff
(99.3 %id)
CX164441 human embryonic stem cells differentiated toan early endodermal cell type .a-u 76 to 796 1 to 721       721/721
(100 %)
0 diff
(100 %id)
CD515778 White Matter .a-u 76 to 979 1 to 911       911/972
(93 %)
19 diff
(98.1 %id)
CF126222 Chondrosarcoma Lung Metastasis cell lines, lung .a-u 76 to 851 1 to 770       770/798
(96 %)
10 diff
(98.8 %id)
TI_57179122   .a-u 76 to 901 31 to 858       828/860
(96 %)
3 diff
(99.7 %id)
BM720105 eye, fetal eye .a-u 76 to 617 1 to 540   fully sequenced,   540/540
(100 %)
4 diff
(99.3 %id)
BC002385 Muscle, rhabdomyosarcoma .a-u 77 to 1242 1 to 1166 exact available from MGC, AAA   1166/1166
(100 %)
0 diff
(100 %id)
BC002410 Muscle, rhabdomyosarcoma .a-u 77 to 1242 1 to 1166   available from MGC, AAA   1166/1166
(100 %)
0 diff
(100 %id)
BU154823 melanotic melanoma, skin .a-u 77 to 715 1 to 642       642/900
(71 %)
33 diff
(96.4 %id)
BF125174 melanotic melanoma, skin .a-u 78 to 674 1 to 603       603/658
(91 %)
29 diff
(95.6 %id)
CN401404 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a-u 79 to 515 1 to 437       437/437
(100 %)
0 diff
(100 %id)
AL539843 brain, fetal brain .a-u 79 to 1097 1 to 1011 A41X P176S W177L T178D V179S ...     1011/1066
(94 %)
21 diff
(98.1 %id)
ES313232 beard hair, skin .a-u 79 to 259 1 to 179       179/179
(100 %)
2 diff
(98.9 %id)
BG748160 eye, normal pigmented retinal epithelium .a-u 79 to 824 1 to 745       745/745
(100 %)
13 diff
(98.3 %id)
BG818557 anaplastic oligodendroglioma with 1p/19qloss, brain .a-u 79 to 860 10 to 789       780/793
(98 %)
20 diff
(97.5 %id)
BI770016 pooled lung and spleen .a-u 79 to 808 1 to 733       733/733
(100 %)
10 diff
(98.7 %id)
BM546620 brain, hippocampus .a-u 79 to 936 16 to 885       870/1134
(76 %)
26 diff
(97.8 %id)
TI_57178331   .a-u 79 to 808 35 to 767       733/767
(95 %)
6 diff
(99.3 %id)
TI_57188409   .a-u 79 to 865 110 to 892       783/786
(99 %)
19 diff
(97.6 %id)
CN401391 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a-u 80 to 716 1 to 637       637/637
(100 %)
0 diff
(100 %id)
CN401403 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a-u 80 to 511 1 to 432       432/432
(100 %)
0 diff
(100 %id)
BI856473 breast, mammary adenocarcinoma, cell line .a-u 80 to 865 1 to 782       782/785
(99 %)
19 diff
(97.6 %id)
CD516984 White Matter .a-u 80 to 468 1 to 392       392/945
(41 %)
8 diff
(99.2 %id)
TI_59393859   .a-u 80 to 867 86 to 873       788/789
(99 %)
8 diff
(99.0 %id)
R12897 whole brain .a-u 81 to 441 1 to 360       360/360
(100 %)
2 diff
(99.5 %id)
BM015607 breast, mammary adenocarcinoma, cell line .a-u 81 to 867 1 to 787       787/788
(99 %)
8 diff
(99.0 %id)
BG394241 eye, retinoblastoma .a-u 82 to 839 1 to 754       754/1131
(66 %)
19 diff
(98.4 %id)
BM019036 astrocytoma grade IV, cell line, brain .a-u 82 to 530 1 to 453       453/854
(53 %)
12 diff
(98.6 %id)
BM020553 astrocytoma grade IV, cell line, brain .a-u 82 to 763 1 to 696       696/888
(78 %)
22 diff
(97.6 %id)
BU553980 ovary, teratocarcinoma, cell line .a-u 82 to 606 73 to 600       528/1297
(40 %)
13 diff
(99.0 %id)
TI_59391342   .a-u 82 to 763 99 to 794       696/888
(78 %)
22 diff
(97.6 %id)
DN990692 brain, whole brain .a-u 82 to 658 1 to 577       577/577
(100 %)
5 diff
(99.2 %id)
AA339351 brain .a-u 83 to 267 1 to 185       185/185
(100 %)
0 diff
(100 %id)
AA359911 lung .a-u 83 to 271 1 to 189       189/189
(100 %)
0 diff
(100 %id)
CN401390 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a-u 83 to 522 1 to 441       441/441
(100 %)
6 diff
(98.7 %id)
BQ636714 eye, retina .a-u 83 to 279 1 to 197       197/197
(100 %)
4 diff
(98.0 %id)
BI829380 brain, medulla .a-u 83 to 309 1 to 221       221/221
(100 %)
6 diff
(97.3 %id)
BM560605 astrocytoma grade IV, cell line, brain .a-u 84 to 636 1 to 552       552/1195
(46 %)
17 diff
(98.6 %id)
BU190395 epithelioid carcinoma, Pancreas .a-u 84 to 662 1 to 590       590/1063
(55 %)
18 diff
(98.4 %id)
CA394779 eye, RPE/choroid .a-u 85 to 598 1 to 517       517/517
(100 %)
6 diff
(98.9 %id)
BU527986 epidermoid carcinoma, cell line, lung .a-u 85 to 824 1 to 749       749/928
(80 %)
15 diff
(98.4 %id)
TI_151811741   .a-u 85 to 484 76 to 475       400/1044
(38 %)
7 diff
(99.4 %id)
CV026676 mixed .a-u 88 to 428 1 to 341       341/516
(66 %)
1 diff
(99.9 %id)
AA122144 Pancreas .a-u 88 to 450 1 to 362       362/362
(100 %)
2 diff
(99.5 %id)
BG118416 adenocarcinoma, cell line, Liver .a-u 88 to 758 1 to 665       665/665
(100 %)
8 diff
(98.8 %id)
BU508303 leiomyosarcoma, uterus .a-u 88 to 677 1 to 596       596/1133
(52 %)
22 diff
(98.1 %id)
DR159427 human embryonic stem cells differentiated toan early endodermal cell type .a-u 88 to 529 1 to 442       442/442
(100 %)
0 diff
(100 %id)
CN401385 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a-u 89 to 644 1 to 557       557/557
(100 %)
1 diff
(99.9 %id)
BF038195 adenocarcinoma, ovary .a-u 90 to 863 1 to 771       771/1082
(71 %)
43 diff
(96.1 %id)
R50584 breast .a-u 91 to 446 20 to 381       362/382
(94 %)
18 diff
(95.3 %id)
BE792155 lung, small cell carcinoma .a-u 91 to 839 1 to 740       740/797
(92 %)
9 diff
(98.9 %id)
BQ932108 epidermoid carcinoma, cell line, lung .a-u 91 to 944 1 to 858       858/933
(91 %)
14 diff
(98.5 %id)
BE408386 choriocarcinoma, placenta .a-u 93 to 758 1 to 661       661/684
(96 %)
11 diff
(98.4 %id)
R12899 whole brain .a-u 94 to 408 1 to 314       314/314
(100 %)
3 diff
(99.1 %id)
AA031540 uterus .a-u 94 to 262 1 to 168   fully sequenced,   168/168
(100 %)
4 diff
(97.7 %id)
BE276197 melanotic melanoma, skin .a-u 94 to 676 1 to 583       583/583
(100 %)
3 diff
(99.5 %id)
BE383976 melanotic melanoma, skin .a-u 94 to 780 1 to 689       689/689
(100 %)
4 diff
(99.5 %id)
BE384472 melanotic melanoma, skin .a-u 94 to 756 1 to 661       661/713
(92 %)
12 diff
(98.4 %id)
BE409252 choriocarcinoma, placenta .a-u 94 to 755 1 to 663       663/723
(91 %)
8 diff
(98.9 %id)
BF033552 adenocarcinoma, ovary .a-u 95 to 772 1 to 668       668/817
(81 %)
20 diff
(97.6 %id)
BF220132 muscle, rhabdomyosarcoma .a-u 96 to 602 1 to 507   fully sequenced,   507/507
(100 %)
0 diff
(100 %id)
BF220005 muscle, rhabdomyosarcoma .a-u 96 to 771 1 to 676       676/738
(91 %)
16 diff
(97.9 %id)
BE541223 cervix .a-u 96 to 759 1 to 664       664/956
(69 %)
15 diff
(98.5 %id)
BM710608 eye, fetal eyes .a-u 97 to 338 1 to 242       242/242
(100 %)
0 diff
(100 %id)
T77312 whole brain .a-u 100 to 479 1 to 376       376/376
(100 %)
14 diff
(96.3 %id)
BE393414 endometrium, adenocarcinoma cell line, uterus .a-u 101 to 602 1 to 503       503/505
(99 %)
4 diff
(99.3 %id)
BE736682 adenocarcinoma, Pancreas .a-u 102 to 712 1 to 625       625/1266
(49 %)
24 diff
(98.2 %id)
BE795963 lung, small cell carcinoma .a-u 102 to 865 1 to 758       758/927
(81 %)
14 diff
(98.5 %id)
DN993303 brain, whole brain .a-u 103 to 765 1 to 663       663/663
(100 %)
4 diff
(99.4 %id)
BM728411 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .a-u 103 to 786 1 to 682       682/682
(100 %)
2 diff
(99.8 %id)
BE889474 leiomyosarcoma, uterus .a-u 105 to 829 1 to 731       731/1125
(64 %)
29 diff
(97.5 %id)
BE618311 eye, retinoblastoma .a-u 106 to 747 1 to 636   fully sequenced,   636/636
(100 %)
6 diff
(99.1 %id)
CN401388 embryonic stem cells, DMSO-treated H9 cellline .a-u 107 to 442 1 to 336       336/336
(100 %)
0 diff
(100 %id)
CN401392 embryonic stem cells, DMSO-treated H9 cellline .a-u 107 to 718 1 to 612       612/612
(100 %)
0 diff
(100 %id)
BG576551 breast, mammary adenocarcinoma, cell line .a-u 108 to 790 1 to 684       684/685
(99 %)
2 diff
(99.8 %id)
CN401382 embryonic stem cells, DMSO-treated H9 cellline .a-u 109 to 319 1 to 211       211/211
(100 %)
1 diff
(99.6 %id)
CN401411 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a-u 113 to 520 1 to 409       409/413
(99 %)
2 diff
(99.6 %id)
BE275827 melanotic melanoma, skin .a-u 114 to 756 1 to 638       638/736
(86 %)
20 diff
(97.3 %id)
CN401402 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a-u 131 to 510 1 to 380       380/391
(97 %)
2 diff
(99.5 %id)
AI087848 pooled .a-u 140 to 406 457 to 191       267/457
(58 %)
0 diff
(100 %id)
BF112046 pooled .a-u 140 to 368 277 to 51       227/277
(81 %)
12 diff
(95.7 %id)
AA031541 uterus .a-u 144 to 289 145 to 1   fully sequenced,   145/145
(100 %)
0 diff
(100 %id)
BF111822 pooled .a-u 147 to 406 450 to 191       260/450
(57 %)
0 diff
(100 %id)
BF112045 pooled .a-u 150 to 406 447 to 191       257/447
(57 %)
0 diff
(100 %id)
CR999412 T-Lymphocytes .a-u 151 to 419 1 to 269       269/269
(100 %)
0 diff
(100 %id)
CT000450 T-Lymphocytes .a-u 151 to 421 1 to 271       271/271
(100 %)
0 diff
(100 %id)
N64112 liver and spleen .a-u 156 to 500 1 to 347       347/356
(97 %)
6 diff
(98.4 %id)
BE881990 leiomyosarcoma, uterus .a-u 156 to 812 1 to 664       664/666
(99 %)
24 diff
(96.4 %id)
T19549   .a-u 161 to 363 1 to 203       203/208
(97 %)
7 diff
(96.7 %id)
BY795166 eye .a-u 162 to 702 13 to 553       541/553
(97 %)
6 diff
(99.0 %id)
BF930239 nervous_tumor .a-u 209 to 572 1 to 364       364/364
(100 %)
4 diff
(99.0 %id)
TI_154192894   .a-u 220 to 773 50 to 603       554/1020
(54 %)
32 diff
(96.9 %id)
CF127477 Chondrosarcoma Lung Metastasis cell lines, lung .a-u 221 to 657 1 to 437       437/437
(100 %)
3 diff
(99.4 %id)
CA777776 Pancreas, Purified pancreatic islet .a-u 224 to 838 1 to 615       615/658
(93 %)
35 diff
(94.7 %id)
TI_59393343   .a-u 227 to 1124 89 to 980 S33R P34H P35R A36R S38P ...     892/932
(95 %)
21 diff
(97.8 %id)
AA323784 brain, cerebellum .a-u 228 to 480 1 to 252       252/252
(100 %)
3 diff
(98.9 %id)
AW964686   .a-u 229 to 672 1 to 448       448/451
(99 %)
26 diff
(94.3 %id)
BM016414 breast, mammary adenocarcinoma, cell line .a-u 230 to 1124 1 to 889 S33R P34H P35R A36R S38P ...     889/929
(95 %)
21 diff
(97.8 %id)
TI_57215971   .a-u 230 to 1141 12 to 926 S87L P88L S89P S90A Q91S ...     915/926
(98 %)
6 diff
(99.4 %id)
AA143113 Pancreas .a-u 232 to 488 1 to 259       259/259
(100 %)
15 diff
(94.3 %id)
BE874020 large cell carcinoma, undifferentiated, lung .a-u 238 to 965 1 to 712       712/872
(81 %)
32 diff
(96.4 %id)
CN401399 embryonic stem cells, cell lines H1, H7, andH9 .a-u 247 to 712 1 to 466       466/466
(100 %)
2 diff
(99.6 %id)
BG291070 bladder, transitional cell papilloma, cell line .a-u 247 to 1007 1 to 748       748/943
(79 %)
18 diff
(98.1 %id)
BF970621 adrenal cortex carcinoma, cell line, adrenal gland .a-u 248 to 997 1 to 749       749/1102
(67 %)
11 diff
(99.1 %id)
BI755056 brain .a-u 249 to 1141 1 to 897 S87L P88L S89P S90A Q91S ...     897/897
(100 %)
28 diff
(96.9 %id)
BM696732 eye, lens .a-u 253 to 644 1 to 392       392/392
(100 %)
0 diff
(100 %id)
D83878   .a-u 261 to 551 1 to 293       293/296
(98 %)
5 diff
(98.4 %id)
BI824444 pooled brain, lung, testis .a-u 264 to 1008 1 to 745       745/746
(99 %)
5 diff
(99.4 %id)
TI_57200873   .a-u 264 to 1008 70 to 814       745/815
(91 %)
5 diff
(99.4 %id)
TI_149287412   .a-u 289 to 1242 1039 to 105 G2X G3X R5P G6R L7P ... AAA   935/1112
(84 %)
49 diff
(95.6 %id)
TI_154120398   .a-u 290 to 1247 1032 to 82 G2X L8X G9A R10G E11X ... AAA   951/1018
(93 %)
18 diff
(98.3 %id)
BI093271 cervix .a-u 340 to 1039 1 to 699 H146T S147A H148I R149A H150I ...     699/703
(99 %)
16 diff
(97.8 %id)
BQ669327 epidermoid carcinoma, cell line, salivary gland .a-u 357 to 897 1 to 544       544/986
(55 %)
33 diff
(96.7 %id)
TI_149289542   .a-u 364 to 1242 971 to 108 G2T G3R G4I R5F G6S ... AAA   864/983
(87 %)
54 diff
(94.6 %id)
BI856920 breast, mammary adenocarcinoma, cell line .a-u 369 to 1018 1 to 646       646/646
(100 %)
6 diff
(99.1 %id)
TI_57187699   .a-u 369 to 1018 53 to 698       646/646
(100 %)
6 diff
(99.1 %id)
CF127571 Chondrosarcoma Lung Metastasis cell lines, lung .a-u 370 to 1053 1 to 682 T204P S205L C206V V207F A209P     682/682
(100 %)
2 diff
(99.8 %id)
TI_154193104   .a-u 370 to 1099 51 to 773 T204P S205L C206V V207F A209P     723/956
(75 %)
9 diff
(99.1 %id)
BM686855.
matches multiple genes
eye, eye anterior segment .a-u 381 to 904 1 to 524     also hits gene ZNF385A 524/524
(100 %)
3 diff
(99.5 %id)
BI053747 placenta_normal .a-u 384 to 764 23 to 403       381/403
(94 %)
11 diff
(97.3 %id)
TI_149294808   .a-u 393 to 1242 915 to 69 G2E G3E G4T G6L L7* AAA   847/966
(87 %)
20 diff
(98.0 %id)
BF338765 brain, glioblastoma with EGFR amplification .a-u 394 to 1155 1 to 762 D189G L190S S191V P192T S193L ...     762/793
(96 %)
28 diff
(96.5 %id)
TI_227712655   .a-u 397 to 1247 920 to 79 G4D R5E G6T L7X L8X ... AAA   842/991
(84 %)
13 diff
(98.7 %id)
TI_154129607   .a-u 401 to 1247 936 to 103 G4D R5E G6D L7X L8* AAA   834/974
(85 %)
29 diff
(97.1 %id)
TI_159721062   .a-u 401 to 1242 941 to 105 G2E G3E G4T G6L L7X ... AAA   837/991
(84 %)
17 diff
(98.3 %id)
TI_149291444   .a-u 404 to 1242 933 to 100 G4D R5E G6T L7X L8S ... AAA   834/936
(89 %)
23 diff
(97.6 %id)
CR456853   .a-u 405 to 1033 1 to 629       629/630
(99 %)
2 diff
(99.7 %id)
D88756 brain .a-u 405 to 1034 1 to 630 exact     630/630
(100 %)
0 diff
(100 %id)
CA866044 Pancreas, Purified pancreatic islet .a-u 411 to 613 1 to 203     Submitted on the opposite strand 203/204
(99 %)
4 diff
(98.1 %id)
BQ669350 epidermoid carcinoma, cell line, salivary gland .a-u 421 to 923 1 to 509       509/1143
(44 %)
26 diff
(97.8 %id)
W95707 heart .a-u 422 to 508 1 to 84       84/96
(87 %)
10 diff
(89.6 %id)
AI346926 adenocarcinoma, colon .a-u 435 to 1242 815 to 11   AAA   805/805
(100 %)
22 diff
(97.3 %id)
BE298236 muscle, rhabdomyosarcoma .a-u 448 to 755 368 to 679       641/765
(83 %)
37 diff
(95.2 %id)
TI_154129224   .a-u 448 to 1242 903 to 115   AAA   789/956
(82 %)
30 diff
(96.9 %id)
BU160259 melanotic melanoma, skin .a-u 460 to 1149 12 to 704       693/920
(75 %)
25 diff
(97.3 %id)
TI_154062154   .a-u 466 to 1242 870 to 100   AAA   771/969
(79 %)
16 diff
(98.4 %id)
BG104357 melanotic melanoma, skin .a-u 473 to 1030 1 to 557       557/557
(100 %)
2 diff
(99.7 %id)
BG477546 melanotic melanoma, skin .a-u 473 to 1223 1 to 750       750/981
(76 %)
19 diff
(98.1 %id)
TI_149313709   .a-u 475 to 1242 868 to 104   AAA   765/931
(82 %)
16 diff
(98.3 %id)
BQ940085 epidermoid carcinoma, cell line, lung .a-u 477 to 1020 1 to 555       555/1243
(44 %)
27 diff
(97.9 %id)
TI_154127004   .a-u 492 to 1242 852 to 110   AAA   743/945
(78 %)
22 diff
(97.7 %id)
CD367165 Alveolar Macrophage, lung .a-u 492 to 1247 769 to 14   AAA   756/756
(100 %)
1 diff
(99.9 %id)
BF220078 muscle, rhabdomyosarcoma .a-u 498 to 1174 683 to 6       678/809
(83 %)
0 diff
(100 %id)
BE729091 melanotic melanoma, skin .a-u 499 to 1022 4 to 534       531/534
(99 %)
6 diff
(98.9 %id)
AW370386 breast .a-u 500 to 670 1 to 169       169/169
(100 %)
4 diff
(97.7 %id)
H61769 ovarian tumor, ovary .a-u 503 to 727 8 to 234       227/236
(96 %)
5 diff
(97.9 %id)
BE620334 large cell carcinoma, undifferentiated, lung .a-u 517 to 1231 1 to 704       704/714
(98 %)
18 diff
(97.5 %id)
BQ962292 leiomyosarcoma, uterus .a-u 522 to 1242 1 to 722   AAA   722/722
(100 %)
1 diff
(99.9 %id)
BX351834.
matches multiple genes
Placenta Cot 25-normalized .a-u 523 to 1239 724 to 1     also hits gene SLC20A1 724/924
(78 %)
24 diff
(97.5 %id)
BU625652 cell lines, Enchondroma .a-u 542 to 1201 678 to 19   AAA   660/660
(100 %)
0 diff
(100 %id)
BM974120 lung .a-u 544 to 1242 718 to 19   AAA   700/700
(100 %)
3 diff
(99.6 %id)
CB305564 lung, Primary Lung Cystic Fibrosis EpithelialCells .a-u 545 to 1242 716 to 19   AAA   698/698
(100 %)
5 diff
(99.3 %id)
BG913788 anaplastic oligodendroglioma with 1p/19qloss, brain .a-u 546 to 952 1 to 412       412/939
(43 %)
9 diff
(99.1 %id)
CB852978 Human Lung Epithelial cells, lung .a-u 547 to 1242 714 to 19   AAA   696/696
(100 %)
1 diff
(99.9 %id)
BM974062 lung .a-u 551 to 1242 708 to 19   AAA   690/690
(100 %)
3 diff
(99.6 %id)
BU683434 lung .a-u 551 to 1242 712 to 19   AAA   694/694
(100 %)
3 diff
(99.6 %id)
TI_154126166   .a-u 556 to 1247 777 to 90   AAA   688/932
(73 %)
8 diff
(99.2 %id)
BQ006648 Chondrosarcoma, Left Pelvis .a-u 559 to 1247 703 to 14   AAA   690/690
(100 %)
1 diff
(99.9 %id)
TI_149309509   .a-u 559 to 1242 781 to 98   AAA   684/959
(71 %)
4 diff
(99.6 %id)
BQ009998 Chondrosarcoma, Left Pubic Bone .a-u 560 to 1247 701 to 14   AAA   688/688
(100 %)
0 diff
(100 %id)
BQ575904 Chondrosarcoma Grade II, Left Pelvis .a-u 560 to 1242 701 to 19   AAA   683/683
(100 %)
1 diff
(99.9 %id)
BU624885 cell lines, Enchondroma .a-u 566 to 1247 699 to 19   AAA   681/681
(100 %)
4 diff
(99.5 %id)
CD368127 Alveolar Macrophage, lung .a-u 570 to 1242 691 to 19   AAA   673/673
(100 %)
1 diff
(99.9 %id)
BF219898 muscle, rhabdomyosarcoma .a-u 572 to 1182 619 to 7   fully sequenced,   613/619
(99 %)
19 diff
(97.0 %id)
BF340909 brain, glioblastoma with EGFR amplification .a-u 574 to 1143 32 to 600       569/600
(94 %)
6 diff
(99.0 %id)
BE539909 cervix .a-u 579 to 1229 1 to 655       655/656
(99 %)
15 diff
(97.8 %id)
BM672027 eye, fetal eye .a-u 587 to 1255 675 to 6   fully sequenced,   670/675
(99 %)
5 diff
(99.3 %id)
AL578837 placenta .a-u 602 to 1218 608 to 1   fully sequenced,   608/608
(100 %)
2 diff
(99.7 %id)
BU687897 lung .a-u 602 to 1242 659 to 19   AAA   641/641
(100 %)
3 diff
(99.6 %id)
TI_149291884   .a-u 606 to 1242 747 to 111   AAA   637/683
(93 %)
15 diff
(97.9 %id)
BU742193 eye, fetal eye .a-u 610 to 1247 651 to 14   AAA   638/638
(100 %)
2 diff
(99.7 %id)
BE044303 pooled .a-u 618 to 1246 629 to 1       629/629
(100 %)
13 diff
(98.0 %id)
BE874615 large cell carcinoma, undifferentiated, lung .a-u 619 to 1243 1 to 628       628/900
(69 %)
14 diff
(98.5 %id)
AW131761 brain, medulloblastoma .a-u 628 to 1246 621 to 3       619/640
(96 %)
0 diff
(100 %id)
C04431 heart .a-u 640 to 1118 1 to 478       478/478
(100 %)
2 diff
(99.6 %id)
BI870250 adenocarcinoma, cell line, Liver .a-u 642 to 1211 8 to 581       574/854
(67 %)
7 diff
(99.2 %id)
TI_57229242   .a-u 642 to 1211 64 to 637       574/854
(67 %)
7 diff
(99.2 %id)
BQ015924 lung, Metastatic Chondrosarcoma .a-u 646 to 1242 615 to 19   AAA   597/597
(100 %)
0 diff
(100 %id)
BQ774399 Chondrosarcoma Grade II, Left Pelvis .a-u 646 to 1242 616 to 19   AAA   598/598
(100 %)
2 diff
(99.7 %id)
CA417833 Chondrosarcoma Cell line .a-u 648 to 1242 613 to 19   AAA   595/595
(100 %)
14 diff
(97.7 %id)
CA421054 Bone, Enchondroma cell line .a-u 648 to 1242 613 to 19   AAA   595/595
(100 %)
1 diff
(99.9 %id)
BF843927 head_neck .a-u 657 to 1177 20 to 542       523/542
(96 %)
6 diff
(98.9 %id)
BM972734 lung .a-u 668 to 1242 592 to 19   AAA   574/574
(100 %)
2 diff
(99.7 %id)
BQ446018 Knee, Osteoarthritic Cartilage .a-u 668 to 1247 593 to 14   AAA   580/580
(100 %)
1 diff
(99.9 %id)
AW168801 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .a-u 669 to 1247 596 to 19   AAA   578/578
(100 %)
39 diff
(93.3 %id)
CA416862 Chondrosarcoma Cell line .a-u 670 to 1242 590 to 19   AAA   572/572
(100 %)
5 diff
(99.2 %id)
BU616710 Bone, Subchondral Bone .a-u 671 to 1242 591 to 19   AAA   573/573
(100 %)
3 diff
(99.5 %id)
BU616150 Bone, Subchondral Bone .a-u 671 to 1247 595 to 19   AAA   577/577
(100 %)
1 diff
(99.9 %id)
BP429946   .a-u 674 to 1024 1 to 351       351/351
(100 %)
3 diff
(99.2 %id)
AW293009   .a-u 675 to 1247 585 to 13   AAA   573/573
(100 %)
1 diff
(99.9 %id)
AA302562 aorta .a-u 677 to 999 1 to 323       323/323
(100 %)
4 diff
(98.8 %id)
BG236148 blood, lymphocyte .a-u 684 to 1248 580 to 16   AAA   565/565
(100 %)
8 diff
(98.6 %id)
N32285 melanocyte .a-u 690 to 1247 554 to 1       554/554
(100 %)
7 diff
(98.8 %id)
BE714839 head_neck .a-u 695 to 1007 9 to 321       313/321
(97 %)
9 diff
(97.2 %id)
BF767746 colon_normal .a-u 698 to 998 1 to 299       299/309
(96 %)
5 diff
(98.4 %id)
BF966855 brain, hippocampus .a-u 698 to 1182 512 to 24   fully sequenced,   489/512
(95 %)
12 diff
(97.7 %id)
AW901005 nervous_normal .a-u 703 to 1055 1 to 353       353/353
(100 %)
2 diff
(99.5 %id)
AA091701   .a-u 714 to 1014 1 to 293       293/293
(100 %)
16 diff
(94.6 %id)
BX395921 Placenta Cot 25-normalized .a-u 715 to 1035 696 to 1008 G17D G18R E22K A36X R40X ...     895/1088
(82 %)
64 diff
(94.2 %id)
BE618819 eye, retinoblastoma .a-u 717 to 1217 514 to 13   fully sequenced,   502/514
(97 %)
7 diff
(98.7 %id)
AA307887 aorta .a-u 719 to 929 1 to 211       211/212
(99 %)
4 diff
(98.2 %id)
AW952063   .a-u 720 to 1245 1 to 526   AAA   526/526
(100 %)
0 diff
(100 %id)
BQ637647 eye, retina .a-u 726 to 1239 1 to 514       514/514
(100 %)
0 diff
(100 %id)
BI524062 pooled lung and spleen .a-u 731 to 1245 1 to 515   AAA   515/515
(100 %)
1 diff
(99.9 %id)
TI_44159935   .a-u 731 to 1242 65 to 576   AAA   512/576
(88 %)
6 diff
(99.0 %id)
BP391508 pancreatic islet .a-u 735 to 1247 1 to 513     Submitted on the opposite strand 513/513
(100 %)
0 diff
(100 %id)
C16717   .a-u 738 to 1074 1 to 337       337/337
(100 %)
0 diff
(100 %id)
BI086052 astrocytoma grade IV, cell line, brain .a-u 740 to 1166 456 to 30       427/456
(93 %)
0 diff
(100 %id)
AI572612 adenocarcinoma, Pancreas .a-u 741 to 1247 525 to 18   AAA   508/508
(100 %)
14 diff
(97.3 %id)
BG272166 normal head/neck tissue .a-u 741 to 1247 515 to 12   AAA   504/504
(100 %)
31 diff
(93.9 %id)
BF821671 kidney_tumor .a-u 744 to 1008 68 to 332       304/332
(91 %)
14 diff
(95.8 %id)
AI129121 senescent fibroblast .a-u 750 to 1250 504 to 4       501/504
(99 %)
0 diff
(100 %id)
AW084103 colon, moderately differentiated adenocarcinoma .a-u 751 to 1243 516 to 23   AAA   494/495
(99 %)
29 diff
(94.2 %id)
AW268414 pooled .a-u 751 to 1029 279 to 1       279/310
(90 %)
24 diff
(92.3 %id)
BQ019829 Chondrosarcoma, Left Pubic Bone .a-u 752 to 1242 509 to 19   AAA   491/528
(92 %)
0 diff
(100 %id)
AA912482 Dorsal root ganglion, peripheral nervous system .a-u 754 to 1247 508 to 14   AAA   495/496
(99 %)
6 diff
(98.8 %id)
AI690965 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .a-u 756 to 1247 501 to 12   AAA   490/490
(100 %)
3 diff
(99.4 %id)
AA379800 skin .a-u 759 to 1126 1 to 372       372/372
(100 %)
4 diff
(99.0 %id)
AA864654 Kidney, kidney tumor .a-u 760 to 1248 489 to 1       489/489
(100 %)
0 diff
(100 %id)
AW241851 pooled .a-u 765 to 1244 480 to 1       480/480
(100 %)
10 diff
(98.0 %id)
AI433113 lymph node, lymphoma, follicular mixed small and largecell .a-u 767 to 1247 520 to 40   AAA   481/481
(100 %)
32 diff
(93.4 %id)
AI027000 parathyroid gland, parathyroid tumor .a-u 775 to 831 57 to 1       57/58
(98 %)
0 diff
(100 %id)
AA987452 carcinoid, lung .a-u 777 to 1250 486 to 4       483/486
(99 %)
0 diff
(100 %id)
AI689611 serous papillary carcinoma, high grade, 2pooled tumors, uterus .a-u 777 to 1242 490 to 24   AAA   467/470
(99 %)
18 diff
(96.2 %id)
EL945661 eyeball .a-u 779 to 1189 1 to 411       411/411
(100 %)
6 diff
(98.6 %id)
W76590 heart .a-u 786 to 1019 1 to 236   fully sequenced,   236/236
(100 %)
0 diff
(100 %id)
AA070647   .a-u 786 to 1004 1 to 215       215/218
(98 %)
7 diff
(96.8 %id)
CA425468 Bone, Subchondral Bone .a-u 788 to 1242 473 to 19   AAA   455/455
(100 %)
11 diff
(97.6 %id)
BQ575555 Chondrosarcoma Grade II, Left Pelvis .a-u 788 to 1247 477 to 19   AAA   459/459
(100 %)
1 diff
(99.8 %id)
N53763 liver and spleen .a-u 789 to 1249 464 to 1       464/464
(100 %)
8 diff
(98.3 %id)
AA971946 pooled .a-u 789 to 1246 459 to 1       459/459
(100 %)
14 diff
(97.0 %id)
AI364088 anaplastic oligodendroglioma, brain .a-u 789 to 1246 455 to 2       454/455
(99 %)
0 diff
(100 %id)
BF969036 adrenal cortex carcinoma, cell line, adrenal gland .a-u 789 to 1245 1 to 464       464/510
(90 %)
12 diff
(97.7 %id)
BU682270 lung .a-u 789 to 1242 471 to 19   AAA   453/453
(100 %)
7 diff
(98.5 %id)
BM692965 eye, Retina Foveal and Macular .a-u 790 to 1241 1 to 452       452/452
(100 %)
0 diff
(100 %id)
N57880 liver and spleen .a-u 792 to 1242 451 to 1       451/451
(100 %)
0 diff
(100 %id)
BU624188 cell lines, Enchondroma .a-u 794 to 1242 469 to 19   AAA   451/451
(100 %)
7 diff
(98.5 %id)
AI202692 Prostate .a-u 795 to 1029 235 to 1       235/235
(100 %)
8 diff
(96.6 %id)
AW117224 pooled .a-u 795 to 1239 450 to 6       445/459
(96 %)
0 diff
(100 %id)
BF969168 adrenal cortex carcinoma, cell line, adrenal gland .a-u 796 to 1250 10 to 476       467/526
(88 %)
20 diff
(96.2 %id)
CD679032 eye, Trabecular meshwork .a-u 799 to 1233 1 to 435       435/435
(100 %)
0 diff
(100 %id)
CA416379 Chondrosarcoma Cell line .a-u 799 to 1247 462 to 14   AAA   449/453
(99 %)
0 diff
(100 %id)
R37532 placenta .a-u 800 to 1122 1 to 332       332/336
(98 %)
13 diff
(96.2 %id)
BU681688 lung .a-u 800 to 1242 461 to 19   AAA   443/443
(100 %)
4 diff
(99.1 %id)
AA374404 lung .a-u 802 to 1137 1 to 333       333/333
(100 %)
4 diff
(98.8 %id)
AI151337 placenta .a-u 802 to 1201 416 to 18   AAA   399/453
(88 %)
13 diff
(97.2 %id)
AI635803 adenocarcinoma, Pancreas .a-u 802 to 1243 480 to 39   AAA   442/449
(98 %)
31 diff
(93.1 %id)
BX105764 pooled germ cell tumors .a-u 803 to 1192 1 to 391       391/391
(100 %)
3 diff
(99.3 %id)
AI086752 senescent fibroblast .a-u 804 to 1246 443 to 2       442/443
(99 %)
0 diff
(100 %id)
BG222456 brain, glioblastoma with probably TP53 mutation andwithout EGFR amplification .a-u 806 to 1242 457 to 22   AAA   436/466
(93 %)
24 diff
(94.9 %id)
R50500 breast .a-u 807 to 1243 443 to 1       443/443
(100 %)
12 diff
(97.3 %id)
AA574095 breast .a-u 808 to 1239 432 to 1       432/432
(100 %)
2 diff
(99.6 %id)
AA150581 Pancreas .a-u 811 to 1242 459 to 28   AAA   432/432
(100 %)
6 diff
(98.7 %id)
BQ773281 Chondrosarcoma Cell line .a-u 811 to 1242 450 to 19   AAA   432/432
(100 %)
6 diff
(98.7 %id)
AW338952 adenocarcinoma, Pancreas .a-u 812 to 1242 443 to 13   AAA   431/463
(93 %)
26 diff
(94.4 %id)
N20809 melanocyte .a-u 813 to 1247 436 to 1       436/436
(100 %)
7 diff
(98.4 %id)
F35111 pectoral muscle (after mastectomy) .a-u 816 to 1012 1 to 189       189/189
(100 %)
9 diff
(95.3 %id)
BP373925 umbilical cord .a-u 818 to 1247 1 to 430   AAA   430/430
(100 %)
0 diff
(100 %id)
AI318400 adenocarcinoma, colon .a-u 820 to 1246 430 to 4       427/431
(99 %)
0 diff
(100 %id)
AI344551 2 pooled tumors (clear cell type), Kidney .a-u 820 to 1250 432 to 2       431/433
(99 %)
0 diff
(100 %id)
BQ028609 placenta, Placenta Choriocarcinoma .a-u 821 to 1247 440 to 14   AAA   427/427
(100 %)
2 diff
(99.6 %id)
F27176 pectoral muscle (after mastectomy) .a-u 824 to 1096 1 to 273       273/273
(100 %)
0 diff
(100 %id)
AI252231 brain, tumor, 5 pooled (see description) .a-u 826 to 1242 417 to 1       417/417
(100 %)
0 diff
(100 %id)
AJ706840 heart .a-u 828 to 1242 21 to 435   AAA   415/435
(95 %)
6 diff
(98.7 %id)
AI570671 anaplastic oligodendroglioma, brain .a-u 828 to 1250 426 to 4       423/426
(99 %)
0 diff
(100 %id)
AA121439 Pancreas .a-u 830 to 1238 413 to 1       413/413
(100 %)
10 diff
(97.6 %id)
AI379564 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a-u 835 to 1250 417 to 2       416/417
(99 %)
0 diff
(100 %id)
AI272771 adenocarcinoma, colon .a-u 837 to 1246 413 to 4       410/413
(99 %)
0 diff
(100 %id)
AI479867 anaplastic oligodendroglioma, brain .a-u 838 to 1242 422 to 18   AAA   405/405
(100 %)
6 diff
(98.6 %id)
CA414118 Chondrosarcoma Grade II, Left Pelvis .a-u 838 to 1247 428 to 19   AAA   410/410
(100 %)
2 diff
(99.6 %id)
AI818858 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) .a-u 839 to 1242 420 to 17   AAA   404/424
(95 %)
23 diff
(94.6 %id)
BU735251 eye, lens .a-u 839 to 1242 422 to 19   AAA   404/404
(100 %)
1 diff
(99.8 %id)
EC481124 Prostate .a-u 840 to 919 1 to 81       81/81
(100 %)
2 diff
(97.6 %id)
AI208309   .a-u 840 to 1250 412 to 2       411/412
(99 %)
0 diff
(100 %id)
BM673689 eye, eye anterior segment .a-u 840 to 1247 426 to 19   AAA   408/408
(100 %)
3 diff
(99.3 %id)
EC452526 Prostate .a-u 841 to 923 1 to 83       83/88
(94 %)
2 diff
(97.8 %id)
EC467396 Prostate .a-u 841 to 923 1 to 83       83/88
(94 %)
2 diff
(97.8 %id)
AI147804 senescent fibroblast .a-u 841 to 1029 189 to 1       189/190
(99 %)
10 diff
(94.8 %id)
AI685794 Prostate .a-u 849 to 1242 405 to 12   AAA   394/394
(100 %)
6 diff
(98.5 %id)
N67674.
matches multiple genes
melanocyte .a-u 853 to 1242 392 to 1     also hits gene DNAJC25-GNG10 392/393
(99 %)
2 diff
(99.5 %id)
R41290 whole brain .a-u 864 to 1242 415 to 26   AAA   390/390
(100 %)
18 diff
(95.4 %id)
AI092787 heart .a-u 864 to 1247 394 to 11   AAA   384/384
(100 %)
0 diff
(100 %id)
BP393821 pancreatic islet .a-u 868 to 1242 1 to 375     Submitted on the opposite strand 375/375
(100 %)
0 diff
(100 %id)
CN401401 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a-u 876 to 1250 9 to 383       375/385
(97 %)
1 diff
(99.8 %id)
F21483 pectoral muscle (after mastectomy) .a-u 877 to 1235 1 to 348       348/348
(100 %)
14 diff
(96.0 %id)
AA076432 Pancreas .a-u 879 to 1242 391 to 28   AAA   364/364
(100 %)
3 diff
(99.2 %id)
F37666 pectoral muscle (after mastectomy) .a-u 880 to 1205 1 to 330       330/330
(100 %)
4 diff
(98.8 %id)
AA320164 adipose tissue, white .a-u 894 to 1245 1 to 353       353/355
(99 %)
2 diff
(99.5 %id)
BU533236 mixed (pool of 40 RNAs) .a-u 896 to 1242 1 to 347   AAA   347/347
(100 %)
1 diff
(99.8 %id)
AI076960 senescent fibroblast .a-u 897 to 1029 133 to 1       133/133
(100 %)
7 diff
(94.8 %id)
AJ571894 pectoral muscle (after mastectomy) .a-u 898 to 1250 1 to 354       354/355
(99 %)
6 diff
(98.4 %id)
F29024 pectoral muscle (after mastectomy) .a-u 899 to 1202 1 to 305       305/305
(100 %)
3 diff
(99.1 %id)
AI298029 carcinoid, lung .a-u 900 to 1247 348 to 1       348/348
(100 %)
1 diff
(99.8 %id)
EC580499 Prostate .a-u 902 to 1003 1 to 100       100/103
(97 %)
4 diff
(96.2 %id)
AI373007 anaplastic oligodendroglioma, brain .a-u 904 to 1242 361 to 23   AAA   339/339
(100 %)
20 diff
(94.2 %id)
F21403 pectoral muscle (after mastectomy) .a-u 906 to 1248 1 to 343       343/343
(100 %)
0 diff
(100 %id)
AA912817 pooled .a-u 906 to 1029 124 to 1       124/126
(98 %)
6 diff
(95.3 %id)
BM468222 leiomyosarcoma, uterus .a-u 919 to 1242 1 to 324   AAA   324/324
(100 %)
0 diff
(100 %id)
BE968565 heart .a-u 920 to 1249 1 to 332       332/889
(37 %)
9 diff
(99.0 %id)
N99144 senescent fibroblast .a-u 924 to 1250 331 to 6       326/333
(97 %)
0 diff
(100 %id)
AI348096 adenocarcinoma, colon .a-u 925 to 1246 325 to 4       322/325
(99 %)
0 diff
(100 %id)
AA550780 normal prostatic epithelial cells, Prostate .a-u 941 to 1210 1 to 270       270/270
(100 %)
2 diff
(99.3 %id)
BG956609 colon .a-u 946 to 1242 1 to 288   AAA   288/288
(100 %)
17 diff
(94.1 %id)
BI053393 placenta_normal .a-u 948 to 1165 3 to 222       220/222
(99 %)
9 diff
(96.0 %id)
AV754979 pituitary tumor .a-u 953 to 1243 169 to 459       291/460
(63 %)
2 diff
(99.6 %id)
AA555038 breast .a-u 958 to 1246 289 to 1       289/289
(100 %)
0 diff
(100 %id)
R85556.
matches multiple genes
brain .a-u 960 to 1237 285 to 6     also hits gene PPA2 280/285
(98 %)
0 diff
(100 %id)
BQ019359 Chondrosarcoma, Left Pubic Bone .a-u 960 to 1247 300 to 14   AAA   287/287
(100 %)
1 diff
(99.7 %id)
AW380265 head_neck .a-u 961 to 1170 27 to 236       210/246
(85 %)
2 diff
(99.2 %id)
AW370383 breast .a-u 970 to 1157 43 to 230       188/230
(81 %)
6 diff
(97.4 %id)
BQ772553 Chondrosarcoma Cell line .a-u 970 to 1247 291 to 14   AAA   278/538
(51 %)
1 diff
(99.9 %id)
BI000567 head_normal .a-u 975 to 1076 1 to 102       102/102
(100 %)
9 diff
(91.2 %id)
BE714414 head_neck .a-u 976 to 1191 23 to 236       214/236
(90 %)
8 diff
(96.7 %id)
N26700 melanocyte .a-u 976 to 1242 267 to 1       267/267
(100 %)
1 diff
(99.7 %id)
EC500496 Prostate .a-u 980 to 1092 1 to 111       111/111
(100 %)
5 diff
(95.5 %id)
AA733171 heart .a-u 980 to 1246 267 to 2       266/267
(99 %)
0 diff
(100 %id)
T33442 brain .a-u 985 to 1242 258 to 1       258/258
(100 %)
0 diff
(100 %id)
BX472811   .a-u 988 to 1151 1 to 164       164/164
(100 %)
2 diff
(98.8 %id)
AA838296 colon, colon tumor .a-u 988 to 1242 280 to 26   AAA   255/255
(100 %)
2 diff
(99.3 %id)
W72596 heart .a-u 989 to 1251 267 to 1   fully sequenced,   267/267
(100 %)
2 diff
(99.3 %id)
BG236725 normal head/neck tissue .a-u 989 to 1247 319 to 61   AAA   259/312
(83 %)
1 diff
(99.7 %id)
BM667322 eye, fetal eyes .a-u 989 to 1243 273 to 19   AAA   255/255
(100 %)
3 diff
(98.9 %id)
BX372955 Neuroblastoma Cot 50-normalized .a-u 990 to 1239 249 to 1   fully sequenced,   249/249
(100 %)
1 diff
(99.6 %id)
BG236760 normal head/neck tissue .a-u 992 to 1247 317 to 61   AAA   257/257
(100 %)
1 diff
(99.7 %id)
BU751933 placenta .a-u 994 to 1243 267 to 18   AAA   250/250
(100 %)
2 diff
(99.2 %id)
AW370441 breast .a-u 995 to 1157 1 to 167       167/167
(100 %)
6 diff
(96.5 %id)
EC500103 Prostate .a-u 999 to 1107 1 to 105       105/105
(100 %)
6 diff
(94.3 %id)
AA716124 heart .a-u 1006 to 1247 271 to 30   AAA   242/242
(100 %)
0 diff
(100 %id)
AL571006 placenta, Placenta Cot 25-normalized .a-u 1007 to 1205 199 to 1   fully sequenced,   199/199
(100 %)
0 diff
(100 %id)
CD676811 eye, Trabecular meshwork .a-u 1023 to 1242 1 to 220   AAA   220/220
(100 %)
2 diff
(99.1 %id)
W95708 heart .a-u 1027 to 1242 215 to 1       215/215
(100 %)
1 diff
(99.6 %id)
R98961 liver and spleen .a-u 1033 to 1242 211 to 1       211/217
(97 %)
2 diff
(99.1 %id)
BQ319674 colon .a-u 1035 to 1181 1 to 143       143/143
(100 %)
12 diff
(91.7 %id)
D61832   .a-u 1036 to 1241 1 to 205       205/206
(99 %)
3 diff
(98.6 %id)
CD678887 eye, Trabecular meshwork .a-u 1046 to 1250 1 to 205       205/235
(87 %)
6 diff
(97.5 %id)
BQ023698 placenta .a-u 1048 to 1242 212 to 18   AAA   195/195
(100 %)
0 diff
(100 %id)
Z39040 brain, total brain .a-u 1074 to 1242 169 to 1       169/169
(100 %)
0 diff
(100 %id)
F10943 brain, total brain .a-u 1093 to 1242 150 to 1       150/150
(100 %)
0 diff
(100 %id)
EC446536 Prostate .a-u 1099 to 1190 1 to 89       89/89
(100 %)
3 diff
(96.7 %id)
AI339190 pooled germ cell tumors .a-u 1104 to 1246 144 to 2       143/144
(99 %)
0 diff
(100 %id)
EC519980 Prostate .a-u 1146 to 1242 113 to 17   AAA   97/102
(95 %)
3 diff
(97.1 %id)
BQ230361 epithelioid carcinoma, Pancreas .b 1 to 334 316 to 660 Q46P tiling clone,   345/780
(44 %)
21 diff
(97.4 %id)
CN401387 embryonic stem cells, DMSO-treated H9 cellline Gene FAM127A, variant not shown         Suspected internal deletion, this clone was ignored    
AA421975 ovarian tumor, ovary Gene FAM127A, variant not shown         Suspected internal deletion, this clone was ignored    
AI742011 pooled Gene FAM127A, variant not shown         Suspected internal deletion, this clone was ignored    
BI912715 brain Gene FAM127A, variant not shown         Suspected internal deletion, this clone was ignored    
BM557029 melanotic melanoma, skin Gene FAM127A, variant not shown         Suspected internal deletion, this clone was ignored    
BU192274 epithelioid carcinoma, Pancreas Gene FAM127A, variant not shown       AAA Suspected internal deletion, this clone was ignored    
TI_57238383   Gene FAM127A, variant not shown         Suspected internal deletion, this clone was ignored    
TI_149291505   Gene FAM127A, variant not shown       AAA Suspected internal deletion, this clone was ignored    
? Gene Summary Gene on genome mRNA:.a-u, .b Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes I